Literature DB >> 30879340

FUS-ALS presenting with myoclonic jerks in a 17-year-old man.

Katherine Claire Dodd1, Rachael Power1, John Ealing1,2, Hisham Hamdalla1,2.   

Abstract

Fused in sarcoma-related amyotrophic lateral sclerosis (FUS-ALS) accounts for 4% of all familial motor neurone disease, but has a much higher incidence in juvenile ALS. We present a case of a 17-year-old British man with rapidly progressive bulbar and respiratory failure. On examination he had weak periocular muscles, neck flexion weakness, and a wasted, fasciculating and weak tongue. There were no sensory, cerebellar, or extrapyramidal features but he had frequent myoclonic jerks of the limbs. Routine bloods were normal and an MRI of the neuroaxis as well as CT chest, abdomen and pelvis were unremarkable. NCS/EMG was consistent with anterior horn cell disorder and EEG showed multiple paroxysmal generalized spike-wave discharges. DNA sequencing demonstrated that he was heterozygous for the c.1483C>T pathogenic nonsense mutation in exon 14 of the FUS gene, consistent with ALS6. This is the first reported case of FUS-ALS presenting with prominent myoclonus.

Entities:  

Mesh:

Year:  2019        PMID: 30879340     DOI: 10.1080/21678421.2019.1582665

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  3 in total

1.  Amyotrophic Lateral Sclerosis and Palatal Myoclonus: An Uncommon Association.

Authors:  Pedro Fraiman; Mario Emilio Dourado; Clecio Godeiro-Junior
Journal:  Mov Disord Clin Pract       Date:  2021-01-07

2.  FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders.

Authors:  Binbin Zhou; Huan Wang; Yu Cai; Han Wen; Lulu Wang; Min Zhu; Yunqing Chen; Yanyan Yu; Xi Lu; Meihong Zhou; Pu Fang; Xiaobing Li; Daojun Hong
Journal:  Brain Behav       Date:  2020-04-19       Impact factor: 2.708

Review 3.  Juvenile Amyotrophic Lateral Sclerosis: A Review.

Authors:  Tanya Lehky; Christopher Grunseich
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.